Joseph Ravenell1, Daichi Shimbo2, John N Booth2, Daniel F Sarpong2, Charles Agyemang2, Danielle L Beatty Moody2, Marwah Abdalla2, Tanya M Spruill2, Amanda J Shallcross2, Adam P Bress2, Paul Muntner2, Gbenga Ogedegbe2. 1. From Department of Population Health, New York University School of Medicine (J.R., T.M.S., A.J.S., G.O.); Department of Medicine, Columbia University, New York (D.S., M.A.); Department of Epidemiology, University of Alabama at Birmingham (J.N.B., P.M.); Center for Minority Health & Health Disparities Research and Education, Xavier University of Louisiana, New Orleans (D.F.S.); Department of Public Health, Amsterdam Medical Centre, University of Amsterdam, The Netherlands (C.A.); Department of Psychology, University of Maryland, Baltimore County (D.L.B.M.); and Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City (A.P.B.). joseph.ravenell@nyumc.org. 2. From Department of Population Health, New York University School of Medicine (J.R., T.M.S., A.J.S., G.O.); Department of Medicine, Columbia University, New York (D.S., M.A.); Department of Epidemiology, University of Alabama at Birmingham (J.N.B., P.M.); Center for Minority Health & Health Disparities Research and Education, Xavier University of Louisiana, New Orleans (D.F.S.); Department of Public Health, Amsterdam Medical Centre, University of Amsterdam, The Netherlands (C.A.); Department of Psychology, University of Maryland, Baltimore County (D.L.B.M.); and Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City (A.P.B.).
Abstract
BACKGROUND: Ambulatory blood pressure (BP) monitoring is the reference standard for out-of-clinic BP measurement. Thresholds for identifying ambulatory hypertension (daytime systolic BP [SBP]/diastolic BP [DBP] ≥135/85 mm Hg, 24-hour SBP/DBP ≥130/80 mm Hg, and nighttime SBP/DBP ≥120/70 mm Hg) have been derived from European, Asian, and South American populations. We determined BP thresholds for ambulatory hypertension in a US population-based sample of African American adults. METHODS: We analyzed data from the Jackson Heart Study, a population-based cohort study comprised exclusively of African American adults (n=5306). Analyses were restricted to 1016 participants who completed ambulatory BP monitoring at baseline in 2000 to 2004. Mean SBP and DBP levels were calculated for daytime (10:00 am-8:00 pm), 24-hour (all available readings), and nighttime (midnight-6:00 am) periods, separately. Daytime, 24-hour, and nighttime BP thresholds for ambulatory hypertension were identified using regression- and outcome-derived approaches. The composite of a cardiovascular disease or an all-cause mortality event was used in the outcome-derived approach. For this latter approach, BP thresholds were identified only for SBP because clinic DBP was not associated with the outcome. Analyses were stratified by antihypertensive medication use. RESULTS: Among participants not taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mm Hg were 134/85 mm Hg, 130/81 mm Hg, and 123/73 mm Hg, respectively. The outcome-derived thresholds for daytime, 24-hour, and nighttime SBP corresponding to a clinic SBP ≥140 mm Hg were 138 mm Hg, 134 mm Hg, and 129 mm Hg, respectively. Among participants taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mm Hg were 135/85 mm Hg, 133/82 mm Hg, and 128/76 mm Hg, respectively. The corresponding outcome-derived thresholds for daytime, 24-hour, and nighttime SBP were 140 mm Hg, 137 mm Hg, and 133 mm Hg, respectively, among those taking antihypertensive medication. CONCLUSIONS: On the basis of the outcome-derived approach for SBP and regression-derived approach for DBP, the following definitions for daytime, 24-hour, and nighttime hypertension corresponding to clinic SBP/DBP ≥140/90 mm Hg are proposed for African American adults: daytime SBP/DBP ≥140/85 mm Hg, 24-hour SBP/DBP ≥135/80 mm Hg, and nighttime SBP/DBP ≥130/75 mm Hg, respectively.
BACKGROUND: Ambulatory blood pressure (BP) monitoring is the reference standard for out-of-clinic BP measurement. Thresholds for identifying ambulatory hypertension (daytime systolic BP [SBP]/diastolic BP [DBP] ≥135/85 mm Hg, 24-hour SBP/DBP ≥130/80 mm Hg, and nighttime SBP/DBP ≥120/70 mm Hg) have been derived from European, Asian, and South American populations. We determined BP thresholds for ambulatory hypertension in a US population-based sample of African American adults. METHODS: We analyzed data from the Jackson Heart Study, a population-based cohort study comprised exclusively of African American adults (n=5306). Analyses were restricted to 1016 participants who completed ambulatory BP monitoring at baseline in 2000 to 2004. Mean SBP and DBP levels were calculated for daytime (10:00 am-8:00 pm), 24-hour (all available readings), and nighttime (midnight-6:00 am) periods, separately. Daytime, 24-hour, and nighttime BP thresholds for ambulatory hypertension were identified using regression- and outcome-derived approaches. The composite of a cardiovascular disease or an all-cause mortality event was used in the outcome-derived approach. For this latter approach, BP thresholds were identified only for SBP because clinic DBP was not associated with the outcome. Analyses were stratified by antihypertensive medication use. RESULTS: Among participants not taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mm Hg were 134/85 mm Hg, 130/81 mm Hg, and 123/73 mm Hg, respectively. The outcome-derived thresholds for daytime, 24-hour, and nighttime SBP corresponding to a clinic SBP ≥140 mm Hg were 138 mm Hg, 134 mm Hg, and 129 mm Hg, respectively. Among participants taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mm Hg were 135/85 mm Hg, 133/82 mm Hg, and 128/76 mm Hg, respectively. The corresponding outcome-derived thresholds for daytime, 24-hour, and nighttime SBP were 140 mm Hg, 137 mm Hg, and 133 mm Hg, respectively, among those taking antihypertensive medication. CONCLUSIONS: On the basis of the outcome-derived approach for SBP and regression-derived approach for DBP, the following definitions for daytime, 24-hour, and nighttime hypertension corresponding to clinic SBP/DBP ≥140/90 mm Hg are proposed for African American adults: daytime SBP/DBP ≥140/85 mm Hg, 24-hour SBP/DBP ≥135/80 mm Hg, and nighttime SBP/DBP ≥130/75 mm Hg, respectively.
Authors: Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong Journal: Am J Med Sci Date: 2004-09 Impact factor: 2.378
Authors: Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang Journal: J Hypertens Date: 2013-09 Impact factor: 4.844
Authors: Emmanuel Keku; Wayne Rosamond; Herman A Taylor; Robert Garrison; Sharon B Wyatt; Michelle Richard; Brenda Jenkins; Lisa Reeves; Daniel Sarpong Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Circulation Date: 2005-02-08 Impact factor: 29.690
Authors: Geoffrey A Head; Anastasia S Mihailidou; Karen A Duggan; Lawrence J Beilin; Narelle Berry; Mark A Brown; Alex J Bune; Diane Cowley; John P Chalmers; Peter R C Howe; Jonathan Hodgson; John Ludbrook; Arduino A Mangoni; Barry P McGrath; Mark R Nelson; James E Sharman; Michael Stowasser Journal: BMJ Date: 2010-04-14
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Y Imai; K Nagai; M Sakuma; H Sakuma; H Nakatsuka; H Satoh; N Minami; M Munakata; J Hashimoto; T Yamagishi Journal: Hypertension Date: 1993-12 Impact factor: 10.190
Authors: Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood Journal: Eur Heart J Date: 2013-06-14 Impact factor: 29.983
Authors: Wanpen Vongpatanasin; Colby Ayers; Hamza Lodhi; Sandeep R Das; Jarett D Berry; Amit Khera; Ronald G Victor; Feng-Chang Lin; Anthony J Viera; Yuichiro Yano; James A de Lemos Journal: Hypertension Date: 2018-12 Impact factor: 10.190
Authors: Yan Li; Lutgarde Thijs; Zhen-Yu Zhang; Kei Asayama; Tine W Hansen; José Boggia; Kristina Björklund-Bodegård; Wen-Yi Yang; Teemu J Niiranen; Angeliki Ntineri; Fang-Fei Wei; Masahiro Kikuya; Takayoshi Ohkubo; Eamon Dolan; Atsushi Hozawa; Ichiro Tsuji; Katarzyna Stolarz-Skrzypek; Qi-Fang Huang; Jesus D Melgarejo; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Lucas Aparicio; Jessica Barochiner; Natasza Gilis-Malinowska; Krzysztof Narkiewicz; Kalina Kawecka-Jaszcz; Gladys E Maestre; Antti M Jula; Jouni K Johansson; Tatiana Kuznetsova; Jan Filipovský; George Stergiou; Ji-Guang Wang; Yutaka Imai; Eoin O'Brien; Jan A Staessen Journal: Hypertension Date: 2019-10-21 Impact factor: 10.190
Authors: Daisuke Kamimura; Loretta R Cain; Robert J Mentz; Wendy B White; Michael J Blaha; Andrew P DeFilippis; Ervin R Fox; Carlos J Rodriguez; Rachel J Keith; Emelia J Benjamin; Javed Butler; Aruni Bhatnagar; Rose M Robertson; Michael D Winniford; Adolfo Correa; Michael E Hall Journal: Circulation Date: 2018-04-16 Impact factor: 29.690
Authors: Yuichiro Yano; Rikki M Tanner; Swati Sakhuja; Byron C Jaeger; John N Booth; Marwah Abdalla; Daniel Pugliese; Samantha R Seals; Gbenga Ogedegbe; Daniel W Jones; Paul Muntner; Daichi Shimbo Journal: JAMA Cardiol Date: 2019-09-01 Impact factor: 14.676
Authors: Abiodun M Adeoye; Bamidele O Tayo; Mayowa O Owolabi; Adewole A Adebiyi; Daniel T Lackland; Richard Cooper; Akinlolu Ojo; Gbenga Ogedegbe Journal: J Clin Hypertens (Greenwich) Date: 2018-04-27 Impact factor: 3.738